The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression

NCT06708156 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

606

Enrollment

OTHER

Sponsor class

Conditions

Myopia
Myopia Progression

Interventions

DRUG: Atropine sulfate eye drops 0.01%
DRUG: Atropine sulfate eye drops 0.02%
DRUG: Placebo eye drops

Sponsor

Oupushifang Pharmaceutical Technology Co., Ltd.

Collaborators

[object Object]
[object Object]